Travaux scientifiques

Doç. Dr. Gülçin Otar Yener

96 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Defining Inactivity of Juvenile Spondyloarthropathies: Delphi Study Among Pediatric Rheumatology Academy ( PeRA ) From Türkiye

    International Journal of Rheumatic Diseases, 2026

    DOI 10.1111/1756-185x.70606 PMID 41821199 Source : OpenAlex

  2. Comment on: How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort: reply

    Rheumatology, 2026

    DOI 10.1093/rheumatology/keaf683 PMID 41390971 Source : ORCID

  3. Psychosocial burden in pediatric familial mediterranean fever: A study of quality of life, sleep habits, maternal mental health, and clinical correlates

    BMC Psychology, 2026

    DOI 10.1186/s40359-026-05501-6 PMID 42773465 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  4. IMPACT OF TUBERCULOSIS SCREENING ON CLINICAL DECISION-MAKING IN PEDIATRIC PATIENTS RECEIVING BIOLOGIC THERAPY: A SINGLE-CENTER REAL-WORLD STUDY

    Eskisehir Medical Journal Eskisehir City Hospital, 2026

    DOI 10.48176/esmj.2026.256 Texte intégral en libre accèsSource : OpenAlex

  5. Hepatitis B Immunity and Vaccine Refusal in Pediatric Rheumatology Patients: Serological Evaluation Before Biologic Therapy

    OSMANGAZİ JOURNAL OF MEDICINE, 2026

    DOI 10.20515/otd.1846110 Texte intégral en libre accèsSource : OpenAlex

  6. Subclinical Small Airway Dysfunction in Clinically Stable Juvenile Idiopathic Arthritis: Relationship with Disease Activity

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa565 Source : OpenAlex

  7. Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices

    Pediatric Rheumatology, 2025

    DOI 10.1186/s12969-025-01080-9 PMID 40069880 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  8. Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal

    Rheumatology, 2025

    DOI 10.1093/rheumatology/keaf221 PMID 40257440 11 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  9. Longitudinal assessment of disease burden in juvenile systemic lupus erythematosus: A multicenter study of activity and damage scores

    Lupus, 2025

    DOI 10.1177/09612033251386091 PMID 41021284 1 citation (Europe PMC) Source : OpenAlex

  10. Three-year follow up of canakinumab dose extension in children with colchicine resistant fasmilial Mediterranean fever: PeRA-RG Experience

    Rheumatology, 2025

    DOI 10.1093/rheumatology/keaf403 PMID 40748721 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  11. ÇOCUKLARDA PFAPA HASTALIĞINDA TONSILLEKTOMI GEREKLILIĞINI ÖNGÖREBILIR MIYIZ?

    Kocaeli Üniversitesi - AVESİS, 2025

    Texte intégral en libre accèsSource : OpenAlex

  12. Is it possible to predict the need for tonsillectomy in children with PFAPA?

    Kocaeli Üniversitesi - AVESİS, 2025

    Source : OpenAlex

  13. How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort

    Rheumatology, 2025

    DOI 10.1093/rheumatology/keaf440 PMID 40811013 3 citations (Europe PMC) Source : ORCID

  14. Evaluation of disease activity and damage index in patients diagnosed with juvenile systemic lupus erythematosus

    Kocaeli Üniversitesi - AVESİS, 2025

    Source : OpenAlex

  15. Exploring factors for predicting colchicine responsiveness in children with PFAPA

    European Journal of Pediatrics, 2024

    DOI 10.1007/s00431-024-05703-3 PMID 39085658 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  16. The journey of MEFV heterozygous children: with or without colchicine

    European Journal of Pediatrics, 2024

    DOI 10.1007/s00431-024-05887-8 PMID 39581919 4 citations (Europe PMC) Source : OpenAlex

  17. Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study

    The Turkish Journal of Pediatrics, 2024

    DOI 10.24953/turkjped.2023.446 PMID 38523382 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  18. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or-6 therapy

    Rheumatology, 2024

    DOI 10.1093/rheumatology/keae124 PMID 38441301 6 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  19. Cognitive performance, psychiatric comorbidities, and quality of life in pediatric patients with juvenile idiopathic arthritis: a comparative analysis with healthy controls

    Child Neuropsychology, 2024

    DOI 10.1080/09297049.2024.2426272 PMID 39569588 5 citations (Scopus) Texte intégral en libre accèsSource : ORCID

  20. How do gene mutation diversity and disease severity scoring affect physical capacity and quality of life in children/adolescents with Familial Mediterranean Fever?

    Reumatologia Clinica, 2024

    DOI 10.1016/j.reuma.2024.05.001 1 citation (Scopus) Source : ORCID

  21. How do gene mutation diversity and disease severity scoring affect physical capacity and quality of life in children/adolescents with Familial Mediterranean Fever?

    Reumatología Clínica (English Edition), 2024

    DOI 10.1016/j.reumae.2024.07.005 PMID 39160007 Source : OpenAlex

  22. Mortality risk factors among critically ill children with MIS-C in PICUs: a multicenter study

    Pediatric Research, 2023

    DOI 10.1038/s41390-023-02518-0 PMID 36813951 9 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  23. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study

    Joint Bone Spine, 2023

    DOI 10.1016/j.jbspin.2023.105559 PMID 36858168 22 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  24. Inflammatory comorbidities ın the largest pediatric Familial Mediterranean fever cohort: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG)

    Clinical Rheumatology, 2023

    DOI 10.1007/s10067-023-06802-6 PMID 37926798 9 citations (Europe PMC) Source : OpenAlex

  25. How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience

    Pediatric Rheumatology, 2023

    DOI 10.1186/s12969-023-00860-5 PMID 37475055 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  26. The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study

    Expert Opinion on Biological Therapy, 2023

    DOI 10.1080/14712598.2023.2282133 PMID 37970654 7 citations (Europe PMC) Source : OpenAlex

  27. PREDICT-crFMF score: A novel model for predicting colchicine resistance in children with familial Mediterranean fever

    Modern Rheumatology, 2023

    DOI 10.1093/mr/road008 PMID 36680425 1 citation (Europe PMC) Source : OpenAlex

  28. Do the features of juvenile psoriatic arthritis change according to age? A comprehensive evaluation of the PeRA Research Group Registry

    Rheumatology, 2023

    DOI 10.1093/rheumatology/kead496 PMID 37725366 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  29. A clinical overview of paediatric sarcoidosis: Multicentre experience from Turkey

    Modern Rheumatology, 2023

    DOI 10.1093/mr/road050 PMID 37243724 4 citations (Europe PMC) Source : OpenAlex

  30. Clinical characteristics and predictors for recurrence in chronic nonbacterial osteomyelitis: a retrospective multicenter analysis

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2023

    DOI 10.55730/1300-0144.5675 PMID 38813038 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  31. Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience

    Pediatric Rheumatology, 2023

    DOI 10.1186/s12969-023-00925-5 PMID 37996934 4 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  32. Initial manifestations and risk factors for calcinosis in juvenile dermatomyositis: A retrospective multicenter study

    Northern Clinics of Istanbul, 2023

    DOI 10.14744/nci.2021.11129 PMID 37435297 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  33. Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG)

    Clinical Rheumatology, 2023

    DOI 10.1007/s10067-023-06677-7 PMID 37378874 2 citations (Europe PMC) Source : ORCID

  34. Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes

    Expert Opinion on Biological Therapy, 2023

    DOI 10.1080/14712598.2023.2185132 PMID 36825474 6 citations (Europe PMC) Source : ORCID

  35. A pediatric case of Takayasu's arteritis with anti- neutrophil cytoplasmic antibody-associated vasculitis triggered by COVID-19 infection

    Northern Clinics of Istanbul, 2023

    DOI 10.14744/nci.2022.01878 PMID 37435294 1 citation (Scopus) Texte intégral en libre accèsSource : ORCID

  36. Frequency of rheumatic diseases in patients with familial Mediterranean fever

    Pamukkale Medical Journal, 2023

    DOI 10.31362/patd.1213710 1 citation (Scopus) Texte intégral en libre accèsSource : Scopus

  37. The validity and reliability of the Juvenile Arthritis Functional Assessment Report (JAFAR) in children/adolescents with Juvenile Idiopathic Arthritis: The Turkish version study

    International Journal of Assessment Tools in Education, 2023

    DOI 10.21449/ijate.1295077 Texte intégral en libre accèsSource : OpenAlex

  38. Semptom-Tanı-Tedavi OLGU SUNUMLARI ile ÇOCUK HASTALIKLARI

    Çanakkale Onsekiz Mart University AVESIS, 2023

    Source : OpenAlex

  39. Real-Life Data From the Largest Pediatric Familial Mediterranean Fever Cohort

    Frontiers in Pediatrics, 2022

    DOI 10.3389/fped.2021.805919 PMID 35127599 59 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  40. Cluster analysis of paediatric Behçet’s disease: Data from The Pediatric Rheumatology Academy-Research Group

    Modern Rheumatology, 2022

    DOI 10.1093/mr/roac044 PMID 35534229 12 citations (Europe PMC) Source : OpenAlex

  41. The Multifaceted Presentation of the Multisystem Inflammatory Syndrome in Children: Data from a Cluster Analysis

    Journal of Clinical Medicine, 2022

    DOI 10.3390/jcm11061742 PMID 35330065 9 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  42. Is it all about age? Clinical characteristics of Kawasaki disease in the extremely young: PeRA research group experience

    Postgraduate Medicine, 2022

    DOI 10.1080/00325481.2022.2058206 PMID 35324413 1 citation (Europe PMC) Source : OpenAlex

  43. Multisystem inflammatory syndrome in children associated with COVID-19 in 101 cases from Turkey (Turk-MISC study).

    Journal of paediatrics and child health, 2022

    DOI 10.1111/jpc.15913 PMID 35199895 18 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  44. Does having MEFV gene sequence variants affect the clinical course and colchicine response in children with PFAPA syndrome?

    European Journal of Pediatrics, 2022

    DOI 10.1007/s00431-022-04709-z PMID 36376520 13 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  45. Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19

    Frontiers in Pediatrics, 2022

    DOI 10.3389/fped.2022.942455 PMID 36061383 23 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  46. 004 Systemic autoinflammatory diseases: a multicenter cohort study

    Rheumatology, 2022

    DOI 10.1093/rheumatology/keac495.004 Texte intégral en libre accèsSource : OpenAlex

  47. Corneal and lenticular clarity in children with inflammatory disease as assessed by Scheimpflug imaging

    Photodiagnosis and Photodynamic Therapy, 2022

    DOI 10.1016/j.pdpdt.2022.103032 PMID 35882290 4 citations (Scopus) Source : ORCID

  48. Hypermobility in Turkish schoolchildren: Musculoskeletal pain, physical activity, balance, and quality of life

    Journal of Contemporary Medicine, 2022

    DOI 10.16899/jcm.1067861 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  49. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-04980-7 PMID 34491393 51 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  50. The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-05008-w PMID 34570263 21 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex